or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
    OU Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    Elitek (Rasburicase) Immuno-Monitoring Study
    Investigational Site Number 4
    Oklahoma City, Oklahoma 73104
    Tumor Lysis Syndrome
    Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Cervical Intraepithelial Neoplasia, Cervical Smears, HPV DNA Probes
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Colorectal Cancer, Metastatic Cancer
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Breast Cancer
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Severe Sepsis
    Tumor Markers in Lung Cancer
    Veterans Affairs Medical Center
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    MS Center of Oklahoma
    Oklahoma City, Oklahoma
    Multiple Sclerosis
    BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Solid Tumors
    New Biomarkers Evaluating Ovarian Cancer
    Oklahoma University Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adnexal Mass
    Tumor Markers in Lung Cancer: DCAMLK-1LK-1
    VAMC-OKC
    Oklahoma City, Oklahoma 73104
    Lung Cancer, Smoking
    Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Salivary Gland Adenoid Cystic Carcinoma, Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVA Salivary Gland Cancer, Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    Efficacy of Aprepitant (Emend®) in Children
    Jimmy Everest Center for Cancer and Blood Disorders in Children
    Oklahoma City, Oklahoma 73104
    Nausea, Vomiting, Childhood Cancer